GLP-1RAs Linked to Reduced Obesity-Related Cancer Risk
GLP-1RA use associated with lower risk of endometrial, ovarian, and meningioma cancers, linked to obesity and hormonal pathways. Explore potential benefits beyond diabetes.
GLP-1RA use associated with lower risk of endometrial, ovarian, and meningioma cancers, linked to obesity and hormonal pathways. Explore potential benefits beyond diabetes.